Published in Metabolism on February 01, 1988
Consequences of excess iodine. Nat Rev Endocrinol (2013) 1.38
Summary of an NIH workshop to identify research needs to improve the monitoring of iodine status in the United States and to inform the DRI. J Nutr (2012) 1.02
Use of iodine for water disinfection: iodine toxicity and maximum recommended dose. Environ Health Perspect (2000) 1.00
Clinical problem-solving. A hidden solution. N Engl J Med (2011) 0.89
Evidence needed to inform the next dietary reference intakes for iodine. Adv Nutr (2013) 0.78
Metallothionein-I/II Knockout Mice Aggravate Mitochondrial Superoxide Production and Peroxiredoxin 3 Expression in Thyroid after Excessive Iodide Exposure. Oxid Med Cell Longev (2015) 0.78
Activation of the Nrf2-Keap 1 Pathway in Short-Term Iodide Excess in Thyroid in Rats. Oxid Med Cell Longev (2017) 0.75
Pediatric TSH Reference Intervals and Prevalence of High Thyroid Antibodies in the Lebanese Population. Int J Endocrinol (2017) 0.75
Iodine Status among Subclinical and Overt Hypothyroid Patients by Urinary Iodine Assay: A Case-Control Study. Indian J Endocrinol Metab (2017) 0.75
Rescue pre-operative treatment with Lugol's solution in uncontrolled Graves' disease. Endocr Connect (2017) 0.75
Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994) J Clin Endocrinol Metab (1998) 3.69
Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA (1995) 3.68
Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J Clin Invest (1970) 3.64
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab (2003) 3.24
Adverse effects of iodides on thyroid function. Med Clin North Am (1975) 2.86
The effect of short-term low-dose perchlorate on various aspects of thyroid function. Thyroid (2000) 2.54
Inorganic phosphate treatment of hypercalcemia of diverse etiologies. N Engl J Med (1966) 2.46
A new method for measuring the free thyroid hormone in human serum and an analysis of the factors that influence its concentration. J Clin Invest (1965) 2.29
Stimulation by phagocytosis of the deiodination of L-thyroxine in human leukocytes. Science (1972) 2.26
Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med (1997) 2.20
Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. J Clin Endocrinol Metab (1997) 2.11
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab (1999) 1.92
Suppression of thyroid radioiodine uptake by various doses of stable iodide. N Engl J Med (1980) 1.88
Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid (1998) 1.76
The effects of amiodarone on the thyroid. Endocr Rev (2001) 1.75
Induction of myxedema by iodide in patients euthyroid after radioiodin or surgical treatment of diffuse toxic goiter. N Engl J Med (1969) 1.70
Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology (1999) 1.70
Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. J Clin Endocrinol Metab (1996) 1.68
Ammonium persulfate: a safe alternative oxidizing reagent for measuring urinary iodine. Clin Chem (1996) 1.64
Diversion of peripheral thyroxine metabolism from activating to inactivating pathways during complete fasting. J Clin Endocrinol Metab (1975) 1.62
Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med (1996) 1.57
Low dose perchlorate (3 mg daily) and thyroid function. Thyroid (2001) 1.57
National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J Clin Endocrinol Metab (2007) 1.52
Determination of total iodine in urine, stool, diets, and tissue. Clin Chem (1965) 1.50
Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients. Ann Intern Med (1989) 1.46
Tear glucose detection of hyperglycemia. Am J Ophthalmol (1968) 1.45
The effects of an acute load of thyroxine on the transport and peripheral metabolism of triiodothyronine in man. J Clin Invest (1970) 1.41
The effect of diltiazem, a calcium channel-blocking drug, on cardiac rate and rhythm in hyperthyroid patients. Arch Intern Med (1988) 1.41
Conjugal Graves disease. Ann Intern Med (1992) 1.39
Iodide-induced hypothyroidism: a potential hazard during perinatal life. Science (1979) 1.39
Effects of fibroblast growth factor on type I 5'-deiodinase in FRTL-5 rat thyroid cells. Endocrinology (1994) 1.37
Evaluation of a simplified technique for the specific measurement of serum thyroxine concentration. J Clin Endocrinol Metab (1971) 1.34
The peripheral metabolism of triiodothyronine in normal subjects and in patients with hyperthyroidism. J Clin Invest (1970) 1.34
Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves'-IgG. Endocrinology (1986) 1.33
The effect of starvation on the concentration and binding of thyroxine and triiodothyronine in serum and on the response to TRH. J Clin Endocrinol Metab (1974) 1.32
Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. J Endocrinol Invest (1986) 1.31
Preparation of I-131-labeled human serum prealbumin and its metabolism in normal and sick patients. J Clin Invest (1965) 1.28
Clinical review 169: Interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects. J Clin Endocrinol Metab (2004) 1.28
The contribution of thyroxine-binding prealbumin to the binding of thyroxine in human serum, as assessed by immunoadsorption. J Clin Invest (1968) 1.26
Lymphocytic thyroiditis and diabetes in the BB/W rat. A new model of autoimmune endocrinopathy. Diabetes (1981) 1.22
Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA (1988) 1.18
Iodide-induced thyrotoxicosis in Boston. N Engl J Med (1972) 1.18
Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents. J Clin Invest (1979) 1.18
Decreased serum testosterone concentration in male heroin and methadone addicts. Steroids (1973) 1.18
Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. Am J Med (1996) 1.16
The influence of fasting, diabetes, and several pharmacological agents on the pathways of thyroxine metabolism in rat liver. J Clin Invest (1978) 1.16
The effect of iodide ingestion on the development of spontaneous lymphocytic thyroiditis in the diabetes-prone BB/W rat. Endocrinology (1986) 1.15
Dietary-induced alterations in thyroid hormone metabolism during overnutrition. J Clin Invest (1979) 1.15
Effect of starvation, nutriment replacement, and hypothyroidism on in vitro hepatic T4 to T3 conversion in the rat. Metabolism (1978) 1.15
Thyroid health status of ammonium perchlorate workers: a cross-sectional occupational health study. J Occup Environ Med (1999) 1.15
Abnormal thyroid function and response to iodides in patients with cystic fibrosis. Trans Assoc Am Physicians (1974) 1.13
Familial dysalbuminemic hyperthyroxinemia: a syndrome that can be confused with thyrotoxicosis. N Engl J Med (1982) 1.13
Management of emergencies. IX. Thyrotoxic storm. N Engl J Med (1966) 1.12
Control of thyroid hormone secretion in normal subjects receiving iodides. J Clin Invest (1973) 1.12
Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab (1994) 1.11
Elevated serum thyroxine concentration in patients receiving "replacement" doses of levothyroxine. J Endocrinol Invest (1982) 1.11
Development and evaluation of a method for the partial purification of immunoglobulins specific for Graves' disease. J Clin Endocrinol Metab (1981) 1.10
Five patients with iodine-induced hyperthyroidism. Am J Med (1984) 1.10
Autoregulation of the thyroid. Response to iodide excess and depletion. Mayo Clin Proc (1972) 1.10
Observations concerning the binding of thyroid hormones in sera of normal subjects of varying ages. J Clin Invest (1966) 1.08
Effects of replacement doses of sodium L-thyroxine on the peripheral metabolism of thyroxine and triiodothyronine in man. J Clin Invest (1973) 1.08
Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis. J Clin Invest (1970) 1.08
Posttraumatic stress disorder in mothers of pediatric cancer survivors. Psychosomatics (1996) 1.08
Active form of the thyroid hormone. Annu Rev Med (1975) 1.08
Schizophrenia and older adults. An overview: directions for research and policy. Am J Geriatr Psychiatry (2000) 1.07
Metabolism of L-thyroxine by phagocytosing human leukocytes. J Clin Invest (1973) 1.07
Demonstration of a saturable binding site for thyrotropin in Yersinia enterocolitica. Science (1983) 1.07
Stimulation of mitochondrial adenosine diphosphate uptake by thyroid hormones. Proc Natl Acad Sci U S A (1973) 1.07
Effect of chronic douching with polyvinylpyrrolidone-iodine on iodine absorption and thyroid function. Obstet Gynecol (1982) 1.06
Inflammatory thyroid disorders. Otolaryngol Clin North Am (1996) 1.06
Stimulation by triiodothyronine of the in vitro uptake of sugars by rat thymocytes. J Clin Invest (1979) 1.06
Human placenta is an active site of thyroxine and 3,3'5-triiodothyronine tyrosyl ring deiodination. J Clin Endocrinol Metab (1981) 1.05
Enhanced susceptibility to iodide myxedema in patients with Hashimoto's disease. J Clin Endocrinol Metab (1971) 1.04
Role of transthyretin in the transport of thyroxine from the blood to the choroid plexus, the cerebrospinal fluid, and the brain. Endocrinology (1992) 1.04
The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. J Clin Invest (1979) 1.03
Studies of the mechanism by which 3,5,3'- triiodothyronine stimulates 2-deoxyglucose uptake in rat thymocytes in vitro. Role of calcium and adenosine 3':5'-monophosphate. J Clin Invest (1981) 1.03
Identification of PTSD in cancer survivors. Psychosomatics (1996) 1.02
Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study). J Clin Endocrinol Metab (1994) 1.02
Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg (2000) 1.02
Perchlorate clinical pharmacology and human health: a review. Ther Drug Monit (2001) 0.99
Observations on the factors that control the generation of triiodothyronine from thyroxine in rat liver and the nature of the defect induced by fasting. J Clin Invest (1979) 0.99
Adenosine 3',5'-monophosphate mediates both the mitogenic effect of thyrotropin and its ability to amplify the response to insulin-like growth factor I in FRTL5 cells. Endocrinology (1988) 0.98